0001209191-14-022917.txt : 20140325
0001209191-14-022917.hdr.sgml : 20140325
20140325140808
ACCESSION NUMBER: 0001209191-14-022917
CONFORMED SUBMISSION TYPE: 4/A
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20140325
FILED AS OF DATE: 20140325
DATE AS OF CHANGE: 20140325
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: NOVAVAX INC
CENTRAL INDEX KEY: 0001000694
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 222816046
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 20 FIRSTFIELD ROAD
CITY: GAITHERSBURG
STATE: MD
ZIP: 20878
BUSINESS PHONE: 240-268-2000
MAIL ADDRESS:
STREET 1: 20 FIRSTFIELD ROAD
CITY: GAITHERSBURG
STATE: MD
ZIP: 20878
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Erck Stanley C
CENTRAL INDEX KEY: 0001342826
FILING VALUES:
FORM TYPE: 4/A
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-26770
FILM NUMBER: 14715519
MAIL ADDRESS:
STREET 1: 20 FIRSTFIELD ROAD, #250
CITY: GAITHERSBURG
STATE: MD
ZIP: 20878
4/A
1
doc4a.xml
FORM 4/A SUBMISSION
X0306
4/A
2014-03-25
2014-03-25
0
0001000694
NOVAVAX INC
NVAX
0001342826
Erck Stanley C
C/O NOVAVAX, INC.
20 FIRSTFIELD ROAD
GAITHERSBURG
MD
20878
1
1
0
0
CEO and President
Common Stock
2014-03-25
4
P
0
10000
4.2698
A
84868
D
The Reporting Person is amending the Form 4 originally filed to report this purchase solely for the purpose of correcting the column 4 code. The correct code is "A".
The reported price is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $4.265 to $4.27, inclusive. The reporting person undertakes to provide to Novavax, Inc., any security holder of Novavax, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each price within the range set forth in this footnote.
/s/ John A. Herrmann III, Attorney-in-Fact
2014-03-25